|
65677360212eaade2e0e12c8
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021643B
|
76_63583
|
1
|
Liberia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.4
|
0.157873
|
0
|
0
|
0.4
|
0.157873
|
0
|
0.4
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677360212eaade2e0e12c9
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021643A
|
76_63583
|
1
|
Liberia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.3
|
0.031422
|
0
|
0
|
0.3
|
0.031422
|
0
|
0.3
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677360212eaade2e0e12ca
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008695
|
76_42350
|
1
|
Mali
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.004282
|
0
|
0
|
0
|
0.004282
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677360212eaade2e0e12cb
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019752D
|
76_61158
|
3
|
Mali
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.127987
|
0
|
0
|
0
|
1.127987
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677360212eaade2e0e12cc
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021644B
|
76_63583
|
1
|
Mali
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.25
|
0.103756
|
0
|
0
|
0.25
|
0.103756
|
0
|
0.25
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677360212eaade2e0e12cd
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021644A
|
76_63583
|
1
|
Mali
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.25
|
0.044156
|
0
|
0
|
0.25
|
0.044156
|
0
|
0.25
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677360212eaade2e0e12ce
|
2020
|
Germany
|
Foreign Office
|
2020008696
|
6614732
|
8
|
Iraq
|
Middle East
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.569801
|
0.569801
|
0
|
0
|
0.569801
|
0.569801
|
|
0.569801
|
|
0
|
Classified as not health-speci...fic activity
more
|
|
100
|
COVID-19 - IMPROVEMENT OF WATE...R SUPPLY AND CASH ASSISTANCE IN IRAQ
more
|
COVID-19 - Improvement of wate...r supply and cash assistance in Iraq
more
|
Improvement of water supply an...d cash assistance to create housing for returnees in relation to the COVID-19 crisis.
more
|
|
12264
|
COVID-19 control
|
|
I.2.b. Basic Health
|
21000
|
International NGO
|
OXFAM International (OXFAM-I)
|
|
COVID-19
|
|
65677360212eaade2e0e12cf
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019753B
|
76_61158
|
1
|
Mozambique
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.4
|
0.598909
|
0
|
0
|
0.4
|
0.598909
|
0
|
|
|
0.4
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12110
|
Health policy and administrati...ve management
more
|
|
I.2.a. Health, General
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677360212eaade2e0e12d0
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019753A
|
76_61158
|
1
|
Mozambique
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.25
|
0.175946
|
0
|
0
|
0.25
|
0.175946
|
0
|
|
|
0.25
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677361212eaade2e0e12d1
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021645
|
76_63583
|
1
|
Mozambique
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0.047922
|
0
|
0
|
0.5
|
0.047922
|
0
|
0.5
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12110
|
Health policy and administrati...ve management
more
|
|
I.2.a. Health, General
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677361212eaade2e0e12d2
|
2020
|
Germany
|
Foreign Office
|
2020008688
|
6614722
|
8
|
Yemen
|
Middle East
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.533333
|
0.533333
|
0
|
0
|
0.533333
|
0.533333
|
|
0.533333
|
|
0
|
COVID-19
|
COVID-19 General
|
100
|
EMERGENCY MEDICAL ASSISTANCE I...N YEMEN IN RELATION TO THE COVID-19 CRISIS
more
|
Emergency medical assistance i...n Yemen in relation to the COVID-19 crisis
more
|
Emergency medical aid for conf...lict-affected host communities and internally displaced persons in Yemen in relation to the COVID-19 crisis
more
|
|
12264
|
COVID-19 control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Donor country-based NGO
|
|
COVID-19
|
|
65677361212eaade2e0e12d3
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021637
|
76_63583
|
1
|
Myanmar
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.25
|
0.117016
|
0
|
0
|
0.25
|
0.117016
|
0
|
0.25
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677361212eaade2e0e12d4
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021646B
|
76_63583
|
1
|
Nepal
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1
|
0.467899
|
0
|
0
|
1
|
0.467899
|
0
|
1
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677361212eaade2e0e12d5
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021646A
|
76_63583
|
1
|
Nepal
|
South & Central Asia
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0.391854
|
0
|
0
|
0.5
|
0.391854
|
0
|
0.5
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677361212eaade2e0e12d6
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008697B
|
76_42350
|
3
|
Nigeria
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.055
|
0
|
0
|
0
|
0.055
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677361212eaade2e0e12d7
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008697A
|
76_42350
|
3
|
Nigeria
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.2
|
0
|
0
|
0
|
0.2
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677361212eaade2e0e12d8
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021647C
|
76_63583
|
1
|
Nigeria
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.3
|
0.188288
|
0
|
0
|
0.3
|
0.188288
|
0
|
0.3
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677361212eaade2e0e12d9
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021647B
|
76_63583
|
1
|
Nigeria
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0.315191
|
0
|
0
|
0.5
|
0.315191
|
0
|
0.5
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677361212eaade2e0e12da
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021647A
|
76_63583
|
1
|
Nigeria
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.2
|
0.114409
|
0
|
0
|
0.2
|
0.114409
|
0
|
0.2
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677362212eaade2e0e12db
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008698A
|
76_42350
|
3
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.336497
|
0
|
0
|
0
|
0.336497
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677362212eaade2e0e12dc
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008698B
|
76_42350
|
3
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.02537
|
0
|
0
|
0
|
0.02537
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES (PQM)
more
|
Promoting the Quality of Medic...ines (PQM)
more
|
Promoting the Quality of Medic...ines (PQM) serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. Supported by knowledgeable staff and state-of-the-art facilities around the world, PQM strives to accomplish four key objectives: Strengthen quality assurance (QA) and quality control (QC) systems, Increase the supply of quality assured medicines, Combat the availability of substandard and counterfeit medicines, and Provide technical leadership and global advocacy.
more
|
0
|
13030
|
Family planning
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677362212eaade2e0e12dd
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021648B
|
76_63583
|
1
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.63
|
0.161006
|
0
|
0
|
1.63
|
0.161006
|
0
|
1.63
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12264
|
COVID-19 control
|
COVID-19
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677362212eaade2e0e12de
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021648A
|
76_63583
|
1
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.357237
|
0.357237
|
0
|
0
|
0.357237
|
0.357237
|
0
|
0.357237
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677362212eaade2e0e12df
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019756B
|
76_61158
|
1
|
Philippines
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.65
|
0
|
0
|
0
|
0.65
|
0
|
0
|
0.65
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677362212eaade2e0e12e0
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019758D
|
76_61158
|
1
|
Senegal
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.5
|
0.623172
|
0
|
0
|
0.5
|
0.623172
|
0
|
|
|
0.5
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677362212eaade2e0e12e1
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021649
|
76_63583
|
1
|
Senegal
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.18
|
0.125629
|
0
|
0
|
0.18
|
0.125629
|
0
|
0.18
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677362212eaade2e0e12e2
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021650
|
76_63583
|
1
|
Serbia
|
Europe
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.145
|
0.010462
|
0
|
0
|
0.145
|
0.010462
|
0
|
0.145
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
25010
|
Business policy and administra...tion
more
|
|
II.5. Business & Other Service...s
more
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677362212eaade2e0e12e3
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019759
|
76_61158
|
3
|
Sierra Leone
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.728832
|
0
|
0
|
0
|
0.728832
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677362212eaade2e0e12e4
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019761D
|
76_61158
|
3
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.291883
|
0
|
0
|
0
|
1.291883
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677362212eaade2e0e12e5
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019760C
|
76_61158
|
3
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
1.080945
|
0
|
0
|
0
|
1.080945
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677363212eaade2e0e12e6
|
2020
|
Germany
|
Foreign Office
|
2020008700
|
6614745
|
8
|
Lebanon
|
Middle East
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.11396
|
0.11396
|
0
|
0
|
0.11396
|
0.11396
|
|
0.11396
|
|
0
|
COVID-19
|
COVID-19 Therapeutics
|
100
|
COVID-19 HEALTH CARE IN LEBANO...N
more
|
COVID-19 Health care in Lebano...n
more
|
Mobile health care for conflic...t-affected Syrian refugees and the receiving Lebanese communities in relation to the COVID-19 crisis
more
|
|
12264
|
COVID-19 control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Donor country-based NGO
|
|
COVID-19
|
|
65677363212eaade2e0e12e7
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020021652
|
76_63583
|
1
|
Uzbekistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.58
|
0.349524
|
0
|
0
|
0.58
|
0.349524
|
0
|
0.58
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
PROMOTING THE QUALITY OF MEDIC...INES PLUS (PQM+)
more
|
Promoting the Quality of Medic...ines Plus (PQM+)
more
|
PQM's goal is to sustainably s...trengthen medical product quality assurance systems in LMICs. PQM+ is designed to work across five interrelated and complementary objectives to facilitate increased technical leadership and global advocacy, collaboration with international partners, and provision of support to integrate and strengthen country medical product quality assurance systems. To achieve this goal, the application of good governance principles to the legal, policy and regulatory functions must be strengthened, the capacity of country and regional institutions and stakeholders needs to be improved to support regular, in-country quality assurance activities, medical product quality assurance efforts need to be supported by optimized information systems and financial and human resources in both the public and private sectors, limited health resources must be generated, invested, and used efficiently, and evidence-based approaches that build on existing health systems and integrate current and future health sector goals and reforms must be developed and applied, advancing the global medical product quality assurance systems strengthening learning, policy, and operational agenda.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65677363212eaade2e0e12e8
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019766
|
76_61158
|
3
|
Western Africa, regional
|
South of Sahara
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.17406
|
0
|
0
|
0
|
0.17406
|
0
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65677363212eaade2e0e12e9
|
2014
|
UNICEF
|
UNICEF
|
2014001257
|
2040/A0/05/905/005
|
8
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.039371
|
0.039371
|
0
|
0
|
0.039371
|
0.039371
|
0
|
0
|
1
|
2
|
Classified as not health-speci...fic activity
more
|
|
100
|
IR 3.1 ADOLESCENTS AND GENDER
|
IR 3.1 ADOLESCENTS AND GENDER
|
IR 3.1 ADOLESCENTS AND GENDER
|
|
11110
|
Education policy and administr...ative management
more
|
|
I.1.a. Education, Level Unspec...ified
more
|
|
|
|
|
|
|
65677364212eaade2e0e12ea
|
2014
|
Asian Development Fund
|
AsDF
|
2014002230
|
LN0708-NEP
|
3
|
Nepal
|
South & Central Asia
|
LDCs
|
ODA Loans
|
4
|
10
|
410
|
C01
|
0
|
0
|
1.66166
|
0
|
0
|
0
|
1.66166
|
0
|
0
|
0
|
Classified as not health-speci...fic activity
more
|
|
100
|
SIXTH POWER PROJECT
|
Sixth Power Project
|
Sixth Power Project
|
|
99810
|
Sectors not specified
|
|
IX. Unallocated / Unspecified
|
12000
|
Recipient government
|
|
|
|
|
65677365212eaade2e0e12eb
|
2014
|
Asian Development Fund
|
AsDF
|
2014001352
|
LN2292-PAK
|
3
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Loans
|
4
|
10
|
410
|
C01
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Classified as not health-speci...fic activity
more
|
|
100
|
IMPROVING ACCESS TO FINANCIAL ...SERVICES (PHASE I) PROGRAM
more
|
Improving Access to Financial ...Services (Phase I) Program
more
|
The goal of the proposed Progr...am is to assist the Government to reduce poverty, build an inclusive financial sector, and promote sustainable economic growth by using technology and applications to lower cost of delivery of financial services and to improve the efficiency of these services. The program's objective is to ensure access to sustainable institutional financial services for most poor and low-income households and their microenterprises at competitive prices. The program will support the Government to improve the performance and efficiences of the financial sector; promote diversification and innovation in product and services delivery; and increase outreach in rural and remote areas. Private sector participation and innovation in the delivery of products and services will be supported including savings services, transfer remittance services, and products and services that are Sharia (Islamic Law) compliant. Increased access to a range of financial services on a sustainable basis will enable the poor to engage in income generating activities, thereby reducing poverty and vulnerability. It will support the Government's core reforms to increase access and accelarate growth nationwide, including programs for literacy.
more
|
|
24010
|
Financial policy & administrat...ive management
more
|
|
II.4. Banking & Financial Serv...ices
more
|
12000
|
Recipient government
|
|
|
|
|
65677365212eaade2e0e12ec
|
2014
|
UNFPA
|
UNFPA
|
2014001430
|
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.258055
|
0.258055
|
0
|
0
|
0.258055
|
0.258055
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
ANALYSIS ON POPULATION DYNAMIC...S
more
|
Output 13: Analysis on populat...ion dynamics
more
|
Executive Office - Outcome 4: ...Strengthened national policies and international development agendas through integration of evidence-based analysis on population dynamics
more
|
Analysis on population dynami...cs
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
|
|
|
|
|
|
65677365212eaade2e0e12ed
|
2014
|
UNFPA
|
UNFPA
|
2014000758
|
|
1
|
China (People's Republic of)
|
Far East Asia
|
UMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0553847
|
0.0553847
|
0
|
0
|
0.0553847
|
0.0553847
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
DATA ON POPULATION AND DEVELOP...MENT
more
|
Output 12: Data on Population ...and Development
more
|
China - Beijing - Outcome 4: S...trengthened national policies and international development agendas through integration of evidence-based analysis on population dynamics
more
|
Data on Population and Develop...ment
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
|
|
|
|
|
|
65677366212eaade2e0e12ee
|
2014
|
UNFPA
|
UNFPA
|
2014002258
|
|
1
|
Kyrgyzstan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.00154103
|
0.00154103
|
0
|
0
|
0.00154103
|
0.00154103
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
DATA ON POPULATION AND DEVELOP...MENT
more
|
Output 12: Data on Population ...and Development
more
|
Kyrgyzstan - Bishkek - Outcome... 4: Strengthened national policies and international development agendas through integration of evidence-based analysis on population dynamics
more
|
Data on Population and Develop...ment
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
|
|
|
|
|
|
65677366212eaade2e0e12ef
|
2014
|
UNICEF
|
UNICEF
|
2014000841
|
297R/A0/08/003/011
|
8
|
South Asia, regional
|
South & Central Asia
|
Part I unallocated by income
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.022368
|
0.022368
|
0
|
0
|
0.022368
|
0.022368
|
0
|
10
|
1
|
11
|
Classified as not health-speci...fic activity
more
|
|
100
|
EMERGENCY & SECURITY
|
EMERGENCY & SECURITY
|
EMERGENCY & SECURITY
|
|
74010
|
Disaster prevention and prepar...edness
more
|
|
VIII.3. Disaster Prevention & ...Preparedness
more
|
|
|
|
|
|
|
65677366212eaade2e0e12f0
|
2014
|
UNFPA
|
UNFPA
|
2014002374
|
|
1
|
Liberia
|
South of Sahara
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.436645
|
0.436645
|
0
|
0
|
0.436645
|
0.436645
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
DATA ON POPULATION AND DEVELOP...MENT
more
|
Output 12: Data on Population ...and Development
more
|
Liberia - Monrovia - Outcome 4...: Strengthened national policies and international development agendas through integration of evidence-based analysis on population dynamics
more
|
Data on Population and Develop...ment
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
|
|
|
|
|
|
65677367212eaade2e0e12f1
|
2014
|
UNFPA
|
UNFPA
|
2014001110
|
|
1
|
Ecuador
|
South America
|
UMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.00219338
|
0.00219338
|
0
|
0
|
0.00219338
|
0.00219338
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
ANALYSIS ON POPULATION DYNAMIC...S
more
|
Output 13: Analysis on populat...ion dynamics
more
|
Ecuador - Quito - Outcome 4: S...trengthened national policies and international development agendas through integration of evidence-based analysis on population dynamics
more
|
Analysis on population dynami...cs
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
|
|
|
|
|
|
65677367212eaade2e0e12f2
|
2014
|
UNFPA
|
UNFPA
|
2014002097
|
|
1
|
Jordan
|
Middle East
|
UMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0752885
|
0.0752885
|
0
|
0
|
0.0752885
|
0.0752885
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
ANALYSIS ON POPULATION DYNAMIC...S
more
|
Output 13: Analysis on populat...ion dynamics
more
|
Jordan - Amman - Outcome 4: St...rengthened national policies and international development agendas through integration of evidence-based analysis on population dynamics
more
|
Analysis on population dynami...cs
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
12000
|
Recipient government
|
|
|
|
|
65677368212eaade2e0e12f3
|
2015
|
UNFPA
|
UNFPA
|
2015002369
|
|
3
|
Guatemala
|
North & Central America
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0
|
0.0557577
|
0
|
0
|
|
0.0557577
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
ANALYSIS ON POPULATION DYNAMIC...S
more
|
Output 13: Analysis on populat...ion dynamics
more
|
Guatemala - Guatemala City. Ou...tput 13: Increased availability of evidence through cutting-edge in-depth analysis on population dynamics, sexual and reproductive health, HIV and their linkages to poverty eradication and sustainable development
more
|
Analysis on population dynami...cs
more
|
16062
|
Statistical capacity building
|
|
I.6. Other Social Infrastructu...re & Services
more
|
12000
|
Recipient government
|
Governments
|
|
|
|
65677369212eaade2e0e12f4
|
2015
|
UNFPA
|
UNFPA
|
2015002668
|
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0
|
0.901762
|
0
|
0
|
|
0.901762
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
ANALYSIS ON POPULATION DYNAMIC...S
more
|
Output 13: Analysis on populat...ion dynamics
more
|
ICPD Beyond 2014 Secretariat. ...Output 13: Increased availability of evidence through cutting-edge in-depth analysis on population dynamics, sexual and reproductive health, HIV and their linkages to poverty eradication and sustainable development
more
|
Analysis on population dynami...cs
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
|
|
UNFPA
|
|
|
|
65677369212eaade2e0e12f5
|
2015
|
UNFPA
|
UNFPA
|
2015002563
|
|
3
|
Haiti
|
North & Central America
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0
|
0.0084167
|
0
|
0
|
|
0.0084167
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
DATA ON POPULATION AND DEVELOP...MENT
more
|
Output 12: Data on Population ...and Development
more
|
Haiti - Port-au-Prince. Output... 12: Strengthened national capacity for production and dissemination of quality disaggregated data on population and development issues that allows for mapping of demographic disparities and socio-economic inequalities, and for programming in humanitarian settings
more
|
Data on Population and Develop...ment
more
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
12000
|
Recipient government
|
Governments
|
|
|
|
65677369212eaade2e0e12f6
|
2015
|
UNICEF
|
UNICEF
|
2015001634
|
4040/A0/01/002/099
|
8
|
South Sudan
|
South of Sahara
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.008275
|
0.008275
|
0
|
0
|
0.008275
|
0.008275
|
0
|
10
|
1
|
11
|
Classified as not health-speci...fic activity
more
|
|
100
|
INTERNAL PROGRAMME DEVELOPMENT
|
INTERNAL PROGRAMME DEVELOPMENT
|
INTERNAL PROGRAMME DEVELOPMENT
|
|
72050
|
Relief co-ordination; protecti...on and support services
more
|
|
VIII.1. Emergency Response
|
|
|
|
|
|
|
6567736a212eaade2e0e12f7
|
2015
|
UNICEF
|
UNICEF
|
2015002834
|
0660/A0/04/002/006
|
8
|
Cambodia
|
Far East Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0561878
|
0.0561878
|
0
|
0
|
0.0561878
|
0.0561878
|
0
|
10
|
0
|
11
|
Classified as not health-speci...fic activity
more
|
|
100
|
SUSTAINABLE WASH ACCESS
|
SUSTAINABLE WASH ACCESS
|
SUSTAINABLE WASH ACCESS
|
|
14010
|
Water sector policy and admini...strative management
more
|
|
I.4. Water Supply & Sanitation
|
|
|
|
|
|
|
6567736a212eaade2e0e12f8
|
2015
|
World Health Organisation
|
WHO
|
2015002839
|
|
1
|
Maldives
|
South & Central Asia
|
UMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0181413
|
0.0181413
|
0
|
0
|
0.0181413
|
0.0181413
|
0
|
0
|
0
|
0
|
Sector-wide health programmes
|
Access to medical products
|
100
|
CVCA: MALDIVESACCESS TO MEDICI...NES AND HEALTH TECHNOLOGIES AND STRENGTHENING REGULATORY CAPACITY
more
|
CVCAMaldivesAccess to Medicine...s and Health Technologies and Strengthening Regulatory Capacity
more
|
Access to Medicines and Health... Technologies and Strengthening Regulatory Capacity
more
|
|
12220
|
Basic health care
|
|
I.2.b. Basic Health
|
|
|
|
0
|
|
|
6567736b212eaade2e0e12f9
|
2015
|
UNFPA
|
UNFPA
|
2015001233
|
|
3
|
China (People's Republic of)
|
Far East Asia
|
UMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0
|
0.00060688
|
0
|
0
|
|
0.00060688
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
ANALYSIS ON POPULATION DYNAMIC...S
more
|
Output 13: Analysis on populat...ion dynamics
more
|
China - Beijing. Output 13: In...creased availability of evidence through cutting-edge in-depth analysis on population dynamics, sexual and reproductive health, HIV and their linkages to poverty eradication and sustainable development
more
|
Analysis on population dynami...cs
more
|
43030
|
Urban development and manageme...nt
more
|
|
IV.2. Other Multisector
|
|
|
UNFPA
|
|
|
